We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Infectious Diseases – News and Features

News

Tecan Boosts RNA Work in France

Tecan's Freedom EVO® Workstation has been used to develop automated in vitro selection techniques for identifying and isolating aptamers.
News

eGene will be Granted Chinese Patent for DNA Analyzer Technology

Company has been granted a patent for "Optical detection in a multi-channel bio-separation system."
News

CytoGenix Enters into Supply Agreement with GE Healthcare

GE will provide CytoGenix with DNA production reagents for use in the manufacture of vaccines and therapeutic compounds by CytoGenix.
News

BioForce Completes $6 Million Private Placement

This funding will facilitate continued development of the company's pipeline technologies.
News

Bourne Research Launches Report Series Covering BioMEMS and Nanotechnology in Medicine

The Bourne Report offers the insightful market analysis available on the emerging use of MEMS and Nanotechnology in medicine.
News

Alnylam Research on miRNAs Featured in The New England Journal of Medicine

The article titled 'MicroRNAs as Therapeutic Targets' discusses clinical applications for intervening with microRNAs.
News

Nastech Presents In Vitro and In Vivo Results with its RNAi Therapeutics Program for Influenza

Nastech believe that targeting the conserved regions could enable a siRNA therapeutic to be effective against both current and future strains of the influenza virus.
News

Cytomics Systems Completes € 10 Million Round of Financing

This round will enable the company to accelerate the development of its antifungal compounds.
News

Oxford Biomedica Licenses its Gene Delivery Technology to Virxsys

The agreement provides Virxsys with rights to utilise BioMedica’s VSV-G viral envelope technology.
News

CytRx Provides 2006 Update on RNAi-Based Drug Discovery Programs

Progress made toward developing next generation molecular medicines to treat obesity and type 2 diabetes.
Advertisement